Skip to main navigation Skip to search Skip to main content

A noncontrolled trial of anti-TNF-alpha chimeric monoclonal antibody (infliximab, Remicade (R)) in exudative age-related macular degeneration

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)e691-e692
JournalActa Ophthalmologica
Volume92
Issue number8
DOIs
Publication statusPublished - 2014

Research programs

  • EMC OR-01-60-01

Cite this